The anti-proliferative properties of 4-benzylphenoxy ethanamine derivatives are mediated by the anti-estrogen binding site (ABS), whereas the anti-estrogenic effects of trifluopromazine are not.

scientific article published in August 1990

The anti-proliferative properties of 4-benzylphenoxy ethanamine derivatives are mediated by the anti-estrogen binding site (ABS), whereas the anti-estrogenic effects of trifluopromazine are not. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/0006-2952(90)90539-W
P698PubMed publication ID2383280

P50authorMarc PoirotQ39184526
P2093author name stringWilson M
Bayard F
Traore M
Garnier M
Faye JC
Riviere I
Fargin A
P433issue3
P407language of work or nameEnglishQ1860
P304page(s)425-429
P577publication date1990-08-01
P1433published inBiochemical PharmacologyQ864229
P1476titleThe anti-proliferative properties of 4-benzylphenoxy ethanamine derivatives are mediated by the anti-estrogen binding site (ABS), whereas the anti-estrogenic effects of trifluopromazine are not.
P478volume40